Abstract

The cytokine interleukin-13 (IL-13) plays a major role in airway inflammation and is a target of new anti-asthmatic drugs. Hence, IL-13 determination could be interesting in assessing therapy success. Thus, in this work an electrochemical immunosensor for IL-13 was developed and integrated into a fluidic system with temperature control for read-out. Therefore, two sets of results are presented. First, the sensor was set up in sandwich format on single-walled carbon nanotube electrodes and was read out by applying the hydrogen peroxide–hydroquinone–horseradish peroxidase (HRP) system. Second, a fluidic system was built up with an integrated heating function realized by Peltier elements that allowed a temperature-controlled read-out of the immunosensor in order to study the influence of temperature on the amperometric read-out. The sensor was characterized at the temperature optimum of HRP at 30 °C and at 12 °C as a reference for lower performance. These results were compared to a measurement without temperature control. At the optimum operation temperature of 30 °C, the highest sensitivity (slope) was obtained compared to lower temperatures and a limit of detection of 5.4 ng/mL of IL-13 was calculated. Taken together, this approach is a first step towards an automated electrochemical immunosensor platform and shows the potential of a temperature-controlled read-out.

Highlights

  • Due to their central role in inflammatory-based diseases, cytokines are considered as potential biomarkers for cancer, asthma, and several other diseases [1]

  • A fluidic system was built up with an integrated heating function realized by Peltier elements that allowed a temperature-controlled read-out of the immunosensor in order to study the influence of temperature on the amperometric read-out

  • Prior to the development of an IL-13 immunosensor, the immunoreagents form the enzyme-linked immunosorbent assays (ELISA) kit were checked by performing an ELISA according to the manufacturer’s protocol (2.4)

Read more

Summary

Introduction

Due to their central role in inflammatory-based diseases, cytokines are considered as potential biomarkers for cancer, asthma, and several other diseases [1]. Plays a central role in respiratory inflammation [2,3] and is a target of new anti-asthmatic drugs [4,5]. Monitoring of IL-13 concentration could be of high interest within the scope of therapy success. Cytokines are monitored via enzyme-linked immunosorbent assays (ELISA) or flow cytometry. One major drawback of these techniques is the long and extensive workflow [1]. In this respect, the development of a cheap and easy-to-use IL-13 biosensor system would be beneficial

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call